MPX NJ

HoneyGrove touts "an inviting environment (and) a comfortable space custom built for an enjoyable-yet-purposeful experience," according to its website. The new facility will open during the following hours:

Monday through Saturday: 10 a.m. to 7 p.m.
Sunday: 12-5 p.m.

Wednesday will also mark HoneyGrove's grand opening.

HoneyGrove will become the second dispensary to open in the township. The first is MPX NJ (581 Berlin-Cross Keys Rd., Sicklerville), which offers both medical and recreational weed.

Early indications look promising, with multiple potential cannabis businesses seeking state licenses to open in the city and more on the way. About $35 million in new investment is expected as part of two large-scale cannabis businesses in town, and MPX NJ, which became the city’s first business open to the recreational cannabis market on New York Avenue on April 20, is building a new and bigger structure right behind the current location.

Cannabis retail culture will finally arrive in the seaside casino resort on Thursday, a year after New Jersey legalized adult-use marijuana.

Mayor Marty Small Sr. signed what he called a “historic business license” granting MPX NJ the right to sell recreational marijuana from their storefront on New York Avenue, just next to the city’s equally pioneering independent coffee shop, Hay Day Coffee, in the historic and newly renovated Bywater Building.

Agri-Kind, a Pennsylvania-based cannabis cultivator and dispenser, is behind the High Rollers Dispensary.

Atlantic City Weed Zone

New Jersey voters legalized recreational marijuana during a 2020 referendum. Recreational cannabis dispensaries are open across the Garden State, but only one has opened near Atlantic City — The Botanist in Egg Harbor Township.

Along with The Botanist, two medicinal-only dispensaries are open in Atlantic City proper — another Botanist location on the Boardwalk and another called MPX NJ along New York Ave.

iAnthus — which acquired MPX NJ earlier this year and opened a medical marijuana dispensary in Atlantic City on May 5 — wants to expand to sell to the adult market there real soon, NJ Advance Media has learned. So does The Botanist, which sells medical weed on the Boardwalk, and is owned by Acreage.

iAnthus is set to appear before the Atlantic City City Council on Wednesday to make its pitch to add adult weed sales at its facility, according to the Council’s meeting agenda posted Friday.

But MPX NJ’s “Be” hasn’t opened its doors off the Boardwalk as planned.

The company’s relationship with its investor iAnthus has soured, and some former leaders at MPX NJ are out. The two companies have argued over which has rights to build out the property and are wrestling now for control over the license. It’s one of only 12 the state has awarded.

As the property languishes, New Jersey’s 113,000 medical marijuana patients struggle to find affordable and accessible cannabis. Many have reported long lines and commutes only to encounter product shortages.

iAnthus (OTC: ITHUF) stock popped over 57% to lately sell at 29 cents after the company was able to close on an $11 million bridge financing funded by certain lenders affiliated with the counterparties to the previously announced restructuring support agreement dated July 10, 2020. They are the holders of all of the 13% senior secured convertible debentures issued by iAnthus Capital Management, LLC and the holders of 91% of the principal amount of 8% convertible unsecured debentures issued by iAnthus.

Two marijuana firms are embroiled in a legal fight over the ownership of a Pleasantville cultivation facility.

MPX NJ, a group owned primarily by Elizabeth Stavola, last week sued iAnthus Capital Management and its New Jersey subsidiary, claiming the company illegally highjacked the operation of the Pleasantville Alternative Treatment Center, for which the two firms hold a shared lease.

MPX NJ, which received one of only 12 vertical MMJ licenses in the state, sued iAnthus last week, claiming iAnthus has tried to take control of its operations, including construction work at a cultivation facility without authorization, after investing $10 million in the business, NJ.com reported.

MPX Bioceutical and iAnthus agreed to merge in late 2018 and entered into an agreement that would transfer ownership from MPX NJ to iAnthus over time.

But that agreement reportedly has yet to be approved by the state Department of Health.